The Ebola outbreak in West Africa isn't showing many signs of slowing. According to the head of the World Health Organization (WHO), the number of new Ebola cases is climbing at such a rate that health authorities are struggling to manage them.

On Sept. 10, the US Food and Drug Administration (FDA) approved a new weight-loss medicine called Contrave. Today, an FDA panel voted to approve another weight-loss medicine.

Diabetes affects millions in the US. But new research suggests that it may affect patients in different ways.

With obesity on the rise, doctors are seeing a rising number of children with gallstones who need a surgical fix. New research suggests these surgeries are safe.

Looking for a less extreme alternative to surgical removal of the organ, a new study assessed the effectiveness of two alternative treatments for kidney cancer patients.

Some patients are less likely than others to undergo surgery to receive a new kidney. New research looked at the concerns that may drive this decision-making in patients.

Diabetes is a disease closely tied to weight, but are patients getting enough exercise to slim down? Maybe not, suggests a new study.

Preventing illness in children is often much easier than treating a disease. But new reports warned that many US kids may not be getting full preventive care.

Exercise improves health in many ways. And a new study suggests it may help children who have problems focusing at school.

The US Food and Drug Administration (FDA) approved a new weight-loss pill Sept. 10 for use in obese and overweight adults.